Biogen Inc.
BIIB
$184.02
-$4.03-2.14%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -10.07% | -4.19% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -10.07% | -4.19% | |||
| Cost of Revenue | -12.82% | -46.25% | |||
| Gross Profit | -9.38% | 19.23% | |||
| SG&A Expenses | 15.59% | 1.98% | |||
| Depreciation & Amortization | -2.58% | 6.51% | |||
| Other Operating Expenses | -19.84% | 16.27% | |||
| Total Operating Expenses | 4.30% | 1.51% | |||
| Operating Income | -42.50% | -14.96% | |||
| Income Before Tax | -110.05% | -25.09% | |||
| Income Tax Expenses | -107.82% | -16.85% | |||
| Earnings from Continuing Operations | -110.48% | -26.51% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -110.48% | -26.51% | |||
| EBIT | -42.50% | -14.96% | |||
| EBITDA | -33.94% | -11.63% | |||
| EPS Basic | -110.47% | -26.56% | |||
| Normalized Basic EPS | -62.13% | -13.21% | |||
| EPS Diluted | -110.51% | -26.79% | |||
| Normalized Diluted EPS | -62.00% | -13.39% | |||
| Average Basic Shares Outstanding | 0.07% | 0.07% | |||
| Average Diluted Shares Outstanding | -0.27% | 0.27% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||